All Articles

Beyond the glitz, China's 'China Night' at Cannes revealed a sophisticated strategy blending AI, ancient arts, and star power to reshape its global image.

With AI compute scattered and complex, a startup by Meta and HRT veterans aims to become the essential operating layer for the entire industry.

Led by OrbiMed, the financing will propel Accro's promising oral RIPK2 inhibitor for Ulcerative Colitis into a pivotal Phase IIb clinical trial.

Hormel Foods declared its 392nd dividend, but a high payout ratio and lagging stock have investors weighing its legendary reliability against current risks.

A new high-yield product is luring Australia's $1.06T SMSF sector. But is the promise of high returns from private credit worth the risk?

A new service offers expert revenue optimization to airlines struggling with a critical shortage of specialized staff, promising significant revenue gains.

A new partnership aims to solve one of biotech's biggest challenges, expanding powerful gene therapies beyond the liver to treat a wider range of diseases.

A new substation is key to China's green energy goals. The real story is the flawless logistical execution that made this massive project possible.

A biotech firm has hatched healthy chicks from artificial eggs, a breakthrough paving the way for de-extinction and a new era in avian conservation.

A coalition of utilities seeks to suspend competitive bidding on grid projects, a move critics say is a power grab that will cost consumers billions.

Chinese FinTech giant Lianlian lands a key license in Dubai, building an AI-driven payment network to power the booming East-West trade corridor.

Filmmaker James Gunn returned to his alma mater with unconventional advice for the Class of 2026, urging them to find purpose beyond their dreams.

The digital bank is rolling out a suite of new investment funds, including a multi-asset portfolio and a physical gold fund, for retail investors.

AI agent developer Vida Global Inc. completes its IPO, but a volatile stock debut raises questions about its future in a booming but competitive industry.

As CRE faces tougher regulations and ESG pressures, Partner bolsters its EHS team with a key hire, signaling a shift toward holistic risk management.

Fresh off a stellar quarter, Everus Construction Group heads to key conferences to detail its role in powering data centers and America's energy transition.

Ozari Health launches a nationwide service for affordable compounded semaglutide, navigating a complex and increasingly regulated market for GLP-1 drugs.

As AI promises flawless communication, one CEO argues that authentic presence, not digital perfection, is the key to leading through uncertainty.

A star-studded launch in Turks and Caicos marks a bold new chapter for Beaches Resorts, blending luxury suites with groundbreaking inclusive tourism.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.